Edit |   |
---|---|
Antigenic Specificity | CSF2, Human (Namilumab biosimilar) |
Clone | Namilumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IP, IF, FuncS, FCM, Neut, ELISA |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CSF2 Recombinant Antibody (Namilumab). Namilumab (alternative identifier MT203) is a human monoclonal antibody (class IgG1 kappa) that targets granulocyte macrophage-colony stimulating factor (GM-CSF)/colony stimulating factor 2 (CSF2) and is currently being researched for application in rheumatoid arthritis (RA) and psoriatic arthritis. |
Immunogen | n/a |
Other Names | Anti-CSF2 Recombinant Antibody, Research Grade Namilumab, Anti-Human CSF2 Recombinant Antibody(Namilumab), MT203, Antibody Drug Analogues, Monoclonal Antibody, YR1246, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1206681-39-1 |
Catalog # | YR1246 |
Price | please inquire |
Order / More Info | CSF2, Human (Namilumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |